Business Context and Reporting Period
This Form 8-K Current Report was filed by UpperCut Brands Inc. (not Silo Pharma, Inc.) on April 20, 2020, covering events occurring on April 15 and April 17, 2020. The company is an emerging growth company incorporated in Delaware. The filing details material definitive agreements, unregistered sales of equity securities, and executive compensation arrangements.
Key Financial Metrics and Capital Structure Changes
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or operating margins. Instead, it reports significant capital structure changes and equity issuances:
- Debt Conversion: All outstanding October 2019 Convertible Notes were exchanged for 4,125,000 shares of Common Stock at $0.08 per share.
- Preferred Stock Conversion: All outstanding Series B Convertible Preferred Stock was exchanged for 1,437,500 shares of Common Stock at $0.08 per share.
- Cash Raised: The company raised $787,643.66 via Subscription Agreements in exchange for 7,864,366 shares of Common Stock.
- Stock-Based Compensation:
- 3,468,841 shares issued for consulting services.
- 5,117,343 shares issued for advisory services.
- 7,630,949 shares granted to the CEO/CFO under a new employment agreement.
Material Changes Versus Prior Period
The primary material change is the complete elimination of the company's October 2019 Convertible Notes and Series B Convertible Preferred Stock liabilities through conversion to equity. Additionally, the company significantly expanded its share count through the issuance of approximately 29.6 million shares of common stock in total across conversions, cash subscriptions, and service-based issuances during this two-day period.
Guidance, Outlook, and Management Commentary
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future business performance. The document focuses strictly on the execution of legal agreements. Key contractual details include:
- Executive Compensation: Eric Weisblum (CEO/CFO) signed a one-year employment agreement with a base salary increase to $120,000, discretionary bonus eligibility, and a grant of 7,630,949 shares. The agreement includes a 60-day termination notice provision.
- Regulatory Status: All securities issued were unregistered, relying on exemptions under Section 4(a)(2) and Rule 506 of Regulation D.
Investor Verification Checklist
- Verify the total authorized share count and the impact of the ~29.6 million new shares on existing shareholder dilution.
- Confirm the current cash balance post-transaction to assess liquidity given the lack of reported revenue.
- Review the full text of the Employment Agreement (Exhibit 10.6) for specific vesting schedules of the CEO's stock grant.
- Check subsequent filings for any updates on the company's operational status or additional capital needs.